| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.5M | -1.5% |
| R&D Expense | $43.8M | -8.9% |
| SG&A Expense | $18.5M | -2.9% |
| Operating Income | -$96.3M | -43.5% |
| Pre-tax Income | -$93.4M | -49.1% |
| Income Tax | $39K | -33.9% |
| Net Income | -$93.4M | -49.1% |
| EPS (Basic) | -$1.43 | -13.5% |
| EPS (Diluted) | -$1.43 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $40.6M | +81.5% |
| Short-term Investments | $0 | -100.0% |
| Current Assets | $43.0M | -59.0% |
| Total Assets | $66.3M | -53.5% |
| Current Liabilities | $12.6M | -35.5% |
| Total Liabilities | $54.8M | +3.0% |
| Stockholders' Equity | $11.6M | -87.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$70.0M | -10.6% |
| Capital Expenditures | $2.3M | +123.3% |
| Investing Cash Flow | $80.3M | +738.2% |
| Financing Cash Flow | $8.5M | -87.0% |
| Free Cash Flow | -$72.3M | -12.4% |
| -13.5% |